Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29

Cinzia Pellizzaro, Danila Coradini, Maria Grazia Daidone

Research output: Contribution to journalArticle

Abstract

Sodium butyrate (NaB), a short-chain fatty acid naturally present in the human colon, is able to induce cell cycle arrest, differentiation and apoptosis in colon cancer cells. In addition to these effects, we investigated the effect of NaB on two angiogenesis-related proteins in a colon carcinoma cell line (HT29): vascular endothelial growth factor (VEGF), the most potent angiogenic factor, and hypoxia-inducible factor (HIF)-1α, the main transcription activator of the VEGF gene, which are both constitutively expressed at high levels in HT29 also in normoxic conditions. NaB treatment had a different effect on VEGF165 and HIF-1α expression. In fact, it induced a dose-dependent down regulation of the VEGF165 protein level that was not paralleled by a concomitant down regulation of the corresponding mRNA, suggesting a post-translational regulation of the factor. Conversely, after 24 h of treatment all the tested NaB concentrations reduced the HIF-1α protein level, whereas after a longer time of exposure HIF-1α level increased in the presence of a high NaB concentration (2 mM) with a concomitant increase in HIF-1α mRNA. These results indicate that NaB, besides regulating other fundamental cellular processes, is able to modulate the expression of two important angiogenesis-related molecules and suggested a further possible clinical application of this short-chain fatty acid as an anti-angiogenic compound in association with conventional chemotherapeutic agents.

Original languageEnglish
Pages (from-to)735-740
Number of pages6
JournalCarcinogenesis
Volume23
Issue number5
Publication statusPublished - 2002

Fingerprint

Hypoxia-Inducible Factor 1
Butyric Acid
Colonic Neoplasms
Cell Line
Volatile Fatty Acids
Proteins
Vascular Endothelial Growth Factor A
Colon
Down-Regulation
Messenger RNA
Angiogenesis Inducing Agents
Cell Cycle Checkpoints
Apoptosis
Carcinoma
Genes

ASJC Scopus subject areas

  • Cancer Research

Cite this

Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. / Pellizzaro, Cinzia; Coradini, Danila; Daidone, Maria Grazia.

In: Carcinogenesis, Vol. 23, No. 5, 2002, p. 735-740.

Research output: Contribution to journalArticle

@article{c891ff59c4514d52b322dd824e4343e7,
title = "Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29",
abstract = "Sodium butyrate (NaB), a short-chain fatty acid naturally present in the human colon, is able to induce cell cycle arrest, differentiation and apoptosis in colon cancer cells. In addition to these effects, we investigated the effect of NaB on two angiogenesis-related proteins in a colon carcinoma cell line (HT29): vascular endothelial growth factor (VEGF), the most potent angiogenic factor, and hypoxia-inducible factor (HIF)-1α, the main transcription activator of the VEGF gene, which are both constitutively expressed at high levels in HT29 also in normoxic conditions. NaB treatment had a different effect on VEGF165 and HIF-1α expression. In fact, it induced a dose-dependent down regulation of the VEGF165 protein level that was not paralleled by a concomitant down regulation of the corresponding mRNA, suggesting a post-translational regulation of the factor. Conversely, after 24 h of treatment all the tested NaB concentrations reduced the HIF-1α protein level, whereas after a longer time of exposure HIF-1α level increased in the presence of a high NaB concentration (2 mM) with a concomitant increase in HIF-1α mRNA. These results indicate that NaB, besides regulating other fundamental cellular processes, is able to modulate the expression of two important angiogenesis-related molecules and suggested a further possible clinical application of this short-chain fatty acid as an anti-angiogenic compound in association with conventional chemotherapeutic agents.",
author = "Cinzia Pellizzaro and Danila Coradini and Daidone, {Maria Grazia}",
year = "2002",
language = "English",
volume = "23",
pages = "735--740",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29

AU - Pellizzaro, Cinzia

AU - Coradini, Danila

AU - Daidone, Maria Grazia

PY - 2002

Y1 - 2002

N2 - Sodium butyrate (NaB), a short-chain fatty acid naturally present in the human colon, is able to induce cell cycle arrest, differentiation and apoptosis in colon cancer cells. In addition to these effects, we investigated the effect of NaB on two angiogenesis-related proteins in a colon carcinoma cell line (HT29): vascular endothelial growth factor (VEGF), the most potent angiogenic factor, and hypoxia-inducible factor (HIF)-1α, the main transcription activator of the VEGF gene, which are both constitutively expressed at high levels in HT29 also in normoxic conditions. NaB treatment had a different effect on VEGF165 and HIF-1α expression. In fact, it induced a dose-dependent down regulation of the VEGF165 protein level that was not paralleled by a concomitant down regulation of the corresponding mRNA, suggesting a post-translational regulation of the factor. Conversely, after 24 h of treatment all the tested NaB concentrations reduced the HIF-1α protein level, whereas after a longer time of exposure HIF-1α level increased in the presence of a high NaB concentration (2 mM) with a concomitant increase in HIF-1α mRNA. These results indicate that NaB, besides regulating other fundamental cellular processes, is able to modulate the expression of two important angiogenesis-related molecules and suggested a further possible clinical application of this short-chain fatty acid as an anti-angiogenic compound in association with conventional chemotherapeutic agents.

AB - Sodium butyrate (NaB), a short-chain fatty acid naturally present in the human colon, is able to induce cell cycle arrest, differentiation and apoptosis in colon cancer cells. In addition to these effects, we investigated the effect of NaB on two angiogenesis-related proteins in a colon carcinoma cell line (HT29): vascular endothelial growth factor (VEGF), the most potent angiogenic factor, and hypoxia-inducible factor (HIF)-1α, the main transcription activator of the VEGF gene, which are both constitutively expressed at high levels in HT29 also in normoxic conditions. NaB treatment had a different effect on VEGF165 and HIF-1α expression. In fact, it induced a dose-dependent down regulation of the VEGF165 protein level that was not paralleled by a concomitant down regulation of the corresponding mRNA, suggesting a post-translational regulation of the factor. Conversely, after 24 h of treatment all the tested NaB concentrations reduced the HIF-1α protein level, whereas after a longer time of exposure HIF-1α level increased in the presence of a high NaB concentration (2 mM) with a concomitant increase in HIF-1α mRNA. These results indicate that NaB, besides regulating other fundamental cellular processes, is able to modulate the expression of two important angiogenesis-related molecules and suggested a further possible clinical application of this short-chain fatty acid as an anti-angiogenic compound in association with conventional chemotherapeutic agents.

UR - http://www.scopus.com/inward/record.url?scp=0036264848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036264848&partnerID=8YFLogxK

M3 - Article

C2 - 12016145

AN - SCOPUS:0036264848

VL - 23

SP - 735

EP - 740

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 5

ER -